Development of a scalable adeno-associated virus purification process for gene therapy

Cell & Gene Therapy Insights 2021; 7(11), 1405


Published: 25 November 2021
Åsa Hagner McWhirter

Watch the video or read the poster to learn how to:

  • Maximize the recovery of the affinity purification step.
  • Remove empty capsids without too much loss of full capsids
  • Avoid analytic pitfalls

Åsa holds a PhD in Medical Biochemistry from Uppsala University in 1999. Åsa has been with the company since 2003, working as a Downstream SME, with a broad and deep understanding of biopharmaceutical application challenges in the area of viral vectors and vaccines, as well as general protein purification and analysis.